In the NSABP B-18 trial, the ipsilateral breast tumor recurrence (IBTR) rate of breast-conserving patients after NAC showed an increasing trend, but the difference was not statistically significant.
← all excerpts
Locoregional recurrence and survival of breast-conserving surgery compared to mastectomy following neoadjuvant chemotherapy in operable breast cancer.
1
—
—